Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03789201 · ClinicalTrials.gov registry record · NA

Exploring the Relationship Between Brain Asymmetry and Attention

A NA study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Completed
Registry status
NA
Development phase
45
Enrollment target

NCT03789201 is a NA study that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 45 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03789201, a NA study, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target

Study Summary

Background: People tend to pay more attention to one side of space than the other and this may be due to differences in the structure and function of the two sides of the brain. We are interested in whether we can detect those difference with magnetic resonance imaging (MRI), transcranial magnetic stimulation (TMS), and electroencephalography (EEG). Objective: The purpose of the study is to understand how differences in brain structure may cause people to pay more attention to one side than the other. Eligibility: Healthy adults ages 18-35 Design: Participants will be screened with a neurological exam. Participants will have 2-3 visits for a total duration of about 7/8 hours. Women of childbearing age must have a negative pregnancy test before each MRI scan. Visits may include: Physical exam Tests of attention, and thinking TMS. A brief electrical current will pass through a wire coil on the scalp. Participants will hear a click and may feel a pull. They may be asked to tense muscles or do tasks. Magnetic resonance imaging (MRI) scan for a maximum of 1 hour. Participants will lie on a table that slides into a cylinder in a strong magnetic field. They will do tasks on a computer screen or lie still. They will get earplugs for loud noise. EEG for no longer than 5 hours, with most lasting 3 hours. Gel and a cap with electrodes will be placed on the scalp. They will record brain waves while the participant gets TMS or does nothing. Questions about participants dominant hand and about the MRI.

Interventions

  • DEVICE TMS EEG
  • DEVICE TMS fMRI

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2019-02-28
Est. Completion 2022-10-24
Phase NA

What the Registry Record Tells You About NCT03789201

The ClinicalTrials.gov registry entry for NCT03789201 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which TMS EEG is the first listed.

NCT03789201 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03789201 about?

NCT03789201 is a clinical study titled "Exploring the Relationship Between Brain Asymmetry and Attention". Background: People tend to pay more attention to one side of space than the other and this may be due to differences in the structure and function of the two sides of the brain. We are interested in whether we can detect those difference with magnetic resonance imaging (MRI), transcranial magnetic ...

What is the current status of trial NCT03789201?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2019-02-28. Estimated completion is 2022-10-24.

What interventions are being tested in trial NCT03789201?

The interventions under investigation include: TMS EEG (DEVICE), TMS fMRI (DEVICE).

Who is sponsoring clinical trial NCT03789201?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.